In summary, these data reveal rare class II-restricted CD8+ T cell responses with potent antiviral properties and clonal expansion in the setting of a natural human viral infection, challenging current paradigms of T cell recognition and restriction. The gene discussed is CD8A; the disease is viral infectious disease.